Company page
Neurogenesis
Neurogenesis, traded under the ticker NEUN, is a public company based in America with a market capitalization of approximately $8.23 billion. The company focuses on innovative approaches in the field of neuroscience. Neurogenesis aims to advance research and development in neuroregenerative therapies.
- Ticker
- NEUN:OTC
- Asset type
- Stock
- Market cap
- $8,226
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD